Clinical studies arising from the Imaging Programme and from collaborations with the Northern Institute for Cancer Research are performed at the Centre.
Members of the Centre are involved in developing pre-clinical contrast media for work on our small bore MRI system.
A cancer research UK phase I trial of AZD3965, a monocarboxylate transporter 1 inhibitor (MCT1) in patients with advanced cancer (Non-Hodgkins Lymphoma. MCT1 Inhibitor study)
Project Leader(s): Professor Ruth Plummer
- Zahra MA, Hollingsworth KG, Sala E, Lomas DJ, Tan LT. Dynamic contrast-enhanced MRI as a predictor of tumour response to radiotherapy. Lancet Oncology 2007; 8(1), 63-74.